NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ:VTYX). The investigation concerns whether Ventyx and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
On November 6, 2023, STAT published an article regarding Ventyx's decision to halt the development of an experimental drug for treating plaque psoriasis. Ventyx's decision was made in spite of ...
VTYX)>Full story available on Benzinga.com